...
首页> 外文期刊>Circulation research: a journal of the American Heart Association >The NHLBI-Sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR) A New Paradigm for Rigorous, Accurate, and Reproducible Evaluation of Putative Infarct-Sparing Interventions in Mice, Rabbits, and Pigs
【24h】

The NHLBI-Sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR) A New Paradigm for Rigorous, Accurate, and Reproducible Evaluation of Putative Infarct-Sparing Interventions in Mice, Rabbits, and Pigs

机译:由NHLBI赞助的用于预防性治疗的临床前评估联合会(CAESAR),这是一种严谨,准确且可重现的小鼠,兔和猪中预防梗塞干预措施评估的新范例

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale: Despite 4 decades of intense effort and substantial financial investment, the cardioprotection field has failed to deliver a single drug that effectively reduces myocardial infarct size in patients. A major reason is insufficient rigor and reproducibility in preclinical studies.
机译:理由:尽管经过4年的艰苦努力和大量财政投入,心脏保护领域仍未能提供一种有效减少患者心肌梗死面积的药物。一个主要原因是临床前研究的严谨性和可重复性不足。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号